Stockreport

Athira Pharma Reports Full Year 2024 Financial Results and Pipeline and Business Updates

Athira Pharma, Inc.  (ATHA) 
PDF Completed healthy volunteer Phase 1 clinical study of ATH-1105 as a potential treatment for amyotrophic lateral sclerosis (ALS) On-track to enable dosing ALS patients i [Read more]